Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$961K Buy
39,925
+3,598
+10% +$94.1K 0.37% 46
2026
Q1
$1.02M Sell
36,327
-6,319
-15% -$168K 0.45% 42
2025
Q4
$1.06M Sell
42,646
-3,228
-7% -$81.4K 0.46% 39
2025
Q3
$1.17M Sell
45,874
-1,060
-2% -$26.2K 0.51% 35
2025
Q2
$1.14M Buy
46,934
+880
+2% +$20.5K 0.53% 33
2025
Q1
$1.17M Sell
46,054
-2,795
-6% -$73.1K 0.6% 29
2024
Q4
$1.3M Buy
48,849
+6,514
+15% +$177K 0.7% 26
2024
Q3
$1.23M Buy
42,335
+930
+2% +$27.1K 0.68% 25
2024
Q2
$1.16M Buy
41,405
+1,543
+4% +$42.5K 0.67% 25
2024
Q1
$1.11M Buy
39,862
+2,582
+7% +$71.6K 0.67% 26
2023
Q4
$1.07M Sell
37,280
-4,170
-10% -$126K 0.71% 30
2023
Q3
$1.37M Buy
41,450
+3,465
+9% +$123K 0.93% 20
2023
Q2
$1.39M Buy
37,985
+219
+0.6% +$8.52K 0.89% 22
2023
Q1
$1.54M Buy
37,766
+955
+3% +$41.2K 1.02% 21
2022
Q4
$1.89M Buy
36,811
+7,268
+25% +$348K 1.31% 19
2022
Q3
$1.29M Buy
29,543
+6,659
+29% +$324K 1.05% 22
2022
Q2
$1.2M Buy
22,884
+842
+4% +$42.9K 0.91% 25
2022
Q1
$1.14M Buy
22,042
+1,177
+6% +$61.1K 0.73% 28
2021
Q4
$1.23M Buy
+20,865
New +$1.03M 0.75% 25
2021
Q1
$1.14M Buy
+22,042
New +$783K 0.73% 28

Other funds holding PFE

626 Financial's PFE Position: Q2 2026 in Review

626 Financial increased its Pfizer (PFE) stake by 9.9% in Q2 2026, buying an estimated $94.1K and bringing the position to 39,925 shares worth $961K. The position accounts for 0.37% of the portfolio, ranked #46.

626 Financial first reported a position in PFE in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.89M in Q4 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • 626 Financial held 39,925 shares of Pfizer worth $961K as of Q2 2026.
  • 626 Financial bought 3,598 Pfizer shares in Q2 2026, an estimated $94.1K.
  • Pfizer made up 0.37% of 626 Financial's portfolio in Q2 2026, its #46 holding.
  • 626 Financial first reported a position in Pfizer in Q1 2021 and has held it in 20 quarters since.
  • 626 Financial's Pfizer position peaked at $1.89M in Q4 2022.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on 626 Financial's 13F filing for Q2 2026, filed 27 Jul 2026.